Ginkgo Bioworks advances collaboration with Novo Nordisk

Ginkgo Bioworks (DNA) announced the completion of the pilot phase of their previously announced partnership with Novo Nordisk (NVO). With the pilot phase completed and the first milestone achieved, the two companies will now move into the development phase to work towards making a more effective production process. Achievement of the first milestone included extensive modification and testing of a microbial expression system to understand the impact of the modifications on key performance parameters.